Identifying predictive biomarkers of apatinib in third-line treatment of advanced colorectal cancer through comprehensive genomic profiling.

Yang, Dongyang; Xu, Fei; Lai, Xiaorong; Li, Ying; Hou, Ting; Wu, Lihong; Ma, Dong; Li, Zijun

Yang, Dongyang; Xu, Fei; Lai, Xiaorong; Li, Ying; Hou, Ting; Wu, Lihong; Ma, Dong; Li, Zijun.

Affiliation

Yang D; Secondary Division of Medical Oncology, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences.
Xu F; Secondary Division of Medical Oncology, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences.
Lai X; Secondary Division of Medical Oncology, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences.
Li Y; Secondary Division of Medical Oncology, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences.
Hou T; Burning Rock Biotech.
Wu L; Burning Rock Biotech.
Ma D; Secondary Division of Medical Oncology, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences.
Li Z; Department of General Practice, Concord Medical Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Anticancer Drugs ; 34(3): 431-438, 2023 03 01.

Article in En | MEDLINE | ID: mdl-36730496

Subject(s)

Antineoplastic Agents; Colorectal Neoplasms; Humans; Antineoplastic Agents/pharmacology; Retrospective Studies; Vascular Endothelial Growth Factor A; Colorectal Neoplasms/pathology; Biomarkers; Genomics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google